Insight Molecular Diagnostics (IMDX) EBT Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -2,855.00 |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 13.00 |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 109.00 |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 10.00 |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 665.00 |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 113.00 |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -53.00 |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -309.00 |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -71.00 |
| 10 | Insight Molecular Diagnostics | 4.52 Mn | -24.41 Mn | 15,000.00 | -1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.35 Mn |
| Dec 31, 2025 | 51,745.00 |
| Sep 30, 2025 | 750,294.00 |
| Jun 30, 2025 | 255,385.00 |
| Mar 31, 2025 | 486,892.00 |
| Dec 31, 2024 | 608,054.00 |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -265,406.00 |
| Mar 31, 2024 | -719,333.00 |
| Dec 31, 2023 | -70,723.00 |
| Sep 30, 2023 | 120,085.00 |
| Jun 30, 2023 | -122,426.00 |
| Mar 31, 2023 | 290,456.00 |
| Dec 31, 2022 | -338,861.00 |
| Sep 30, 2022 | -131,099.00 |
| Jun 30, 2022 | 2,974.00 |
| Mar 31, 2022 | 12,346.00 |
| Dec 31, 2021 | 28,873.00 |
| Sep 30, 2021 | -18,028.00 |
| Jun 30, 2021 | 576,396.00 |